Sponsored articles « Društvo Medicinski razgledi

Post-authorization Safety and Efficacy Study of Olanzapine (Zolrix®) in the Treatment of Schizophrenia and Bipolar Mania

Bon Jurij, Barbič - Žagar Breda, Bevec Matevž

Schizophrenia and bipolar disorder are mental disorders that pose a real problem to the public health care system. Early diagnosis and treatment is instrumental in a relatively good management and control of these two diseases. Second-generation antipsychotics increase the likelihood of selecting the right, optimal medicine, which enables effective treatment at reduced strength and frequency of adverse reactions. We conducted … Preberite več >>

Post-Authorization Safety and Efficacy Study of Escitalopram (Ecytara®) in the Treatment of Depression and Anxiety Disorders

Kapš Peter, Zupanc Nina

BACKGROUNDS. Depression is the most common mental disorder and is a serious mental illness. It is a mental disorder that pose a real problem to the public health care system. Early diagnosis and treatment is instrumental in a relatively good management and control of disease. Selective serotonin reuptake inhibitors are first-line drugs for depression treatment according to guidelines. METHODS. We

… Preberite več >>

Clinical experience with high doses of atorvastatin

Barbič - Žagar Breda, Kos Jernej, Grošelj Mateja

Cardiovascular diseases (CVDs) represent an important healthcare problem in Europe. Among the objectives of cardiovascular disease prevention a more rigorous risk factor control is needed, including control of cholesterol levels. In clinical practice, reaching the target lipid values may be difficult which could be easier achievable by using high doses of statins. Therefore we conducted a study with atorvastatin 40mg … Preberite več >>

Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients

Barbič Žagar Breda, Ristovski Aleksandar, Dular Meglič Tina

Second generation antipsychotics are currently the drugs of choice for the treatment of schizophrenia and bipolar mania, as well as for behavioural symptoms in patients with dementia. All these diseases represent an important healthcare problem in Europe, so that early treatment is recommended. Due to improved patient compliance, new pharmaceutical forms of already proven therapy are developed. Orally disintegrated tablets

… Preberite več >>

NEWS

ARCHIVE

AUTHORS

CONTACT

Archive » 2011 » 1 »

Post-authorization Safety and Efficacy Study of Olanzapine (Zolrix®) in the Treatment of Schizophrenia and Bipolar Mania

Post-Authorization Safety and Efficacy Study of Escitalopram (Ecytara®) in the Treatment of Depression and Anxiety Disorders

Clinical experience with high doses of atorvastatin

Evaluation of Efficacy, Safety and Acceptability of Orodispersible Risperidone in Patients with Schizophrenia, Bipolar Mania and Behavioural Disturbances in Dementia Patients